50歳以上の成人を対象とした、GSKバイオロジカルズの帯状疱疹ワクチンGSK1437173Aの有効性、安全性、免疫原性を評価する研究

基本情報

NCT ID: NCT01165177
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 16,165
治験依頼者名: GlaxoSmithKline

概要

The purpose of this observer-blind study is to evaluate the efficacy, safety and immunogenicity of GSK Biologicals' candidate Herpes Zoster (HZ) vaccine in adults aged ≥ 50 years. Two studies \[ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229)\] are being conducted concurrently to evaluate efficacy of GSK1437173A vaccine. A pooled analysis of data from both studies combined will be conducted contingent on each study achieving its objectives. The protocol posting of study ZOSTER-022 also deals with the outcome measures related to the pooled analysis.

対象疾患

Herpes Zoster

介入

Herpes Zoster Vaccine GSK1437173A(BIOLOGICAL)

Placebo(BIOLOGICAL)

依頼者（Sponsor）

グラクソ・スミスクライン株式会社(INDUSTRY)